Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

Summary

This Phase 2 clinical trial is a multi-center, randomized, double-blind, placebo-controlled, multiple-dose, parallel-cohort study to assess the efficacy, safety and tolerability of VDA-1102 in the treatment of actinic keratosis (AK) on the head of male and female adult subjects.

Timeline

Start

2016-07-15

Primary completion

2017-05-26

Completion

2017-05-26

Outcome

Missed primary endpoint

registry analysis (other test); Placebo vs 5% VDA-1102; p = 0.9518; ANCOVA NCT02844777 ↗

registry analysis (other test); Placebo vs 10% VDA-1102; p = 0.2458; ANCOVA NCT02844777 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VDA-1102	Unknown	5 %	Topical
Subject	VDA-1102	Unknown	10 %	Topical

Indications